Carr A - Search Results

1

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.

Kelleher AD, Carr A, Zaunders J, Cooper DA. Kelleher AD, et al. Among authors: carr a. J Infect Dis. 1996 Feb;173(2):321-9. doi: 10.1093/infdis/173.2.321. J Infect Dis. 1996. PMID: 8568292 Clinical Trial.

2

Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes.

Zaunders J, Carr A, McNally L, Penny R, Cooper DA. Zaunders J, et al. Among authors: carr a. AIDS. 1995 Jun;9(6):561-6. doi: 10.1097/00002030-199506000-00005. AIDS. 1995. PMID: 7662193

3

Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS.

Carr A, Swanson C, Penny R, Cooper DA. Carr A, et al. J Infect Dis. 1993 Jan;167(1):180-5. doi: 10.1093/infdis/167.1.180. J Infect Dis. 1993. PMID: 8380290

4

Primary infection with zidovudine-resistant human immunodeficiency virus type 1 does not adversely affect outcome at 1 year. Sydney Primary HIV Infection Study Group.

Imrie A, Carr A, Duncombe C, Finlayson R, Vizzard J, Law M, Kaldor J, Penny R, Cooper DA. Imrie A, et al. Among authors: carr a. J Infect Dis. 1996 Jul;174(1):195-8. doi: 10.1093/infdis/174.1.195. J Infect Dis. 1996. PMID: 8655994

5

HIV protease inhibitors.

Carr A, Cooper DA. Carr A, et al. AIDS. 1996;10 Suppl A:S151-7. doi: 10.1097/00002030-199601001-00021. AIDS. 1996. PMID: 8883623 Review. No abstract available.

6

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.

Carr A, Emery S, Kelleher A, Law M, Cooper DA. Carr A, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):320-6. doi: 10.1097/00042560-199612010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8948369 Clinical Trial.

7

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication.

de Jong MD, Vella S, Carr A, Boucher CA, Imrie A, French M, Hoy J, Sorice S, Pauluzzi S, Chiodo F, Weverling GJ, van der Ende ME, Frissen PJ, Weigel HM, Kauffmann RH, Lange JM, Yoon R, Moroni M, Hoenderdos E, Leitz G, Cooper DA, Hall D, Reiss P. de Jong MD, et al. Among authors: carr a. J Infect Dis. 1997 Apr;175(4):966-70. doi: 10.1086/514002. J Infect Dis. 1997. PMID: 9086161

8

Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens.

Kelleher AD, Roggensack M, Emery S, Carr A, French MA, Cooper DA. Kelleher AD, et al. Among authors: carr a. Clin Exp Immunol. 1998 Jul;113(1):85-91. doi: 10.1046/j.1365-2249.1998.00633.x. Clin Exp Immunol. 1998. PMID: 9697988 Free PMC article. Clinical Trial.

9

Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals.

Kaufmann GR, Duncombe C, Cunningham P, Beveridge A, Carr A, Sayer D, French M, Cooper DA. Kaufmann GR, et al. Among authors: carr a. AIDS. 1998 Sep 10;12(13):1625-30. doi: 10.1097/00002030-199813000-00009. AIDS. 1998. PMID: 9764781 Clinical Trial.

10

Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.

Carr A, Cooper DA. Carr A, et al. N Engl J Med. 1998 Oct 29;339(18):1296. doi: 10.1056/NEJM199810293391806. N Engl J Med. 1998. PMID: 9791146 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,487 results

Search Page